Groupama Asset Managment Has $14.07 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Groupama Asset Managment boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 19.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 47,131 shares of the company's stock after acquiring an additional 7,601 shares during the period. Groupama Asset Managment's holdings in HCA Healthcare were worth $14,065,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MML Investors Services LLC raised its stake in shares of HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company's stock worth $7,241,000 after buying an additional 4,285 shares during the last quarter. Meritage Group LP bought a new position in shares of HCA Healthcare in the 3rd quarter worth $150,548,000. Galvin Gaustad & Stein LLC bought a new stake in HCA Healthcare in the fourth quarter valued at about $18,044,000. NRI Wealth Management LC bought a new position in HCA Healthcare during the fourth quarter worth about $2,896,000. Finally, Czech National Bank increased its stake in shares of HCA Healthcare by 4.5% in the 4th quarter. Czech National Bank now owns 39,543 shares of the company's stock valued at $11,869,000 after acquiring an additional 1,691 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

HCA traded up $1.75 on Wednesday, reaching $347.48. The company had a trading volume of 1,249,318 shares, compared to its average volume of 1,349,682. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company's fifty day moving average is $326.35 and its 200 day moving average is $340.30. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market cap of $85.55 billion, a P/E ratio of 15.82, a P/E/G ratio of 1.10 and a beta of 1.68.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm earned $5.90 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is 13.11%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Bank of America dropped their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 27th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.